FDA Okays Pitolisant (Wakix) for Narcolepsy

07:40 EDT 15 Aug 2019 | Medscape

The FDA has approved pitolisant, a first-in-class, nonscheduled treatment option with a novel mechanism of action for adults with narcolepsy.
FDA Approvals

Original Article: FDA Okays Pitolisant (Wakix) for Narcolepsy


More From BioPortfolio on "FDA Okays Pitolisant (Wakix) for Narcolepsy"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...